SenzaGen AB (OM:SENZA) is looking for acquisitions. Peter Nahlstedt, Chief Executive Officer said, "We think that acquisitions can really accelerate also our organic growth because it can add commercially operating labs, which we need to perform more GARD tests. It also adds to our knowledge and technology, giving us a more effective R&D to develop new tests.

And we are working on a gross list of more than 100 companies, which we're looking at. We think there is an opportunity to perform smaller-size acquisitions, but also a larger size if we can secure financing".